Evaxion Biotech A/S
NASDAQ:EVAX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Evaxion Biotech A/S
NASDAQ:EVAX
|
DK |
|
Ibio Inc
F:0JV
|
US |
|
S
|
Surteco Group SE
F:SUR
|
DE |
|
Freehold Royalties Ltd
TSX:FRU
|
CA |
|
E
|
Eagle Cold Storage Enterprise Co Ltd
TPEX:8905
|
TW |
|
R
|
RL Commercial REIT Inc
XPHS:RCR
|
PH |
|
B
|
Basler AG
DUS:BSL
|
DE |
|
G
|
Galectin Therapeutics Inc
SWB:PHPN
|
US |
|
OPKO Health Inc
NASDAQ:OPK
|
US |
Wall St Price Targets
EVAX Price Targets Summary
Evaxion Biotech A/S
According to Wall Street analysts, the average 1-year price target for
EVAX is 11.48 USD with a low forecast of 9.09 USD and a high forecast of 16.8 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EVAX's stock price target?
Price Target
11.48
USD
According to Wall Street analysts, the average 1-year price target for
EVAX is 11.48 USD with a low forecast of 9.09 USD and a high forecast of 16.8 USD.
What is the Revenue forecast for Evaxion Biotech A/S?
Projected CAGR
62%
The compound annual growth rate for Revenue over the next 8 years is 62%.